Alex Abramson

Georgia Institute of Technology

Papers

2

Total Citations

51

H-Index

2

About

Alex Abramson is a pioneering researcher at the intersection of bioelectronics, drug delivery, and closed-loop therapeutic systems. His work focuses on developing innovative communication protocols that seamlessly integrate wearable, ingestible, and implantable devices to enable autonomous, real-time treatment of chronic conditions like diabetes and wound healing. In his highly cited 2023 paper (40 citations), Abramson advanced the field of body-conformal sensors and tissue-interfacing robotics, creating frameworks for closed-loop therapies that combine monitoring with automated drug delivery. More recently, his 2024 work (11 citations) introduced electromechanical convective drug delivery devices that overcome the diffusion barriers limiting traditional hydrogels and nanoparticles—a critical breakthrough for improving drug targeting and extending therapeutic profiles in cancer and diabetes treatment. By addressing the fundamental mass transport limitations of passive systems, Abramson’s research bridges engineering and medicine, offering scalable solutions for precision healthcare. His contributions are shaping next-generation bioelectronic medicines, where devices not only sense physiological changes but actively respond to them, promising transformative outcomes for patients with complex, chronic diseases.

Research Focus

Key Achievements

2
H-Index
2
Papers
51
Total Citations
26
Avg Citations/Paper
🏆 Most Cited Paper
Communication protocols integrating wearables, ingestibles, and implantables for closed-loop therapies
40 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Georgia Institute of Technology

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago